shutterstock_750766525_alessandro_zappalorto
Alessandro Zappalorto / Shutterstock.com
24 January 2020Big PharmaEdward Pearcey

CJEU upholds EMA’s right to publish drug firms’ clinical trial data

The Court of Justice of the European Union (CJEU) has rejected two appeals that would have restricted the European Medicines Agency’s right to publish a pharmaceutical company’s clinical trial data, as it relates to their applications to market their products within the EU.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
1 July 2026   The Otsuka v Sun Pharma appeal could redefine which pharmaceutical patents qualify for patent term extensions, with major implications for innovator companies, generic manufacturers and the future of market exclusivity in Australia.
Big Pharma
18 June 2026   Despite a slowdown in US patent litigation, life sciences remains one of the most active sectors—but companies are using a wider than ever IP toolkit, says a new study.
Big Pharma
15 April 2026   The Danish pharma giant is turning to artificial intelligence as it faces patent expiry, falling shares and intensifying competition from Eli Lilly.